Literature DB >> 15482156

Host response to Neisseria meningitidis lacking lipopolysaccharides.

Petter Brandtzaeg1.   

Abstract

Plasma levels of lipopolysaccharides are closely associated with disease manifestations and outcomes in meningococcal infections. The knockout mutant lpxA-Neisseria meningitidis completely lacking lipopolysaccharides has made it possible to study the contribution of nonlipopolysaccharide molecules in the bacterial cell wall to the host's response. The lpxA-N. meningitidis requires 10- to 100-fold higher concentrations of bacteria to elicit the same level of pro-inflammatory cytokines (tumor necrosis factor-alpha, interleukin-1beta and -6) as the wild type parent strain. It activates human mononuclear peripheral blood cells through CD14 and Toll-like receptor-2 receptor complex whereas the wild type strain activates these cells through the CD14-Toll-like receptor-4-MD2 pathway. Dendritic cells are hardly activated by the lpxA-N. meningitidis. It is as efficient as the wild type strain in activating complement. The lpxA-N. meningitidis expresses pili but does not adhere or invade mucosal cells normally. The defensin-mediated adhesion of lpxA-N. meningitidis to the respiratory epithelial cells is severely reduced as compared with the wild-type strain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15482156     DOI: 10.1586/14787210.1.4.589

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  2 in total

1.  Cloning, expression, purification and crystallization of an endotoxin-biosynthesis enzyme from Neisseria meningitidis.

Authors:  Anandhi Anandan; Susannah Piek; Charlene M Kahler; Alice Vrielink
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-11-14

2.  Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease.

Authors:  Reidun Øvstebø; Petter Brandtzaeg; Berit Brusletto; Kari Bente Foss Haug; Knut Lande; Ernst Arne Høiby; Peter Kierulf
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.